金双歧+思密达治疗小儿腹泻30例的临床效果探究

Clinical study on gold dichotomous combined with smecta in the treatment of 30 cases with infantile diarrhea

目的探索金双歧联合思密达治疗小儿腹泻的临床效果。方法选取2013年8月至2014年8月我院收治的60例腹泻患儿,将患儿按动态随机化原则分为两组,各30例。对照组和观察组分别采用常规治疗和金双歧联合思密达治疗,观察两组患儿的临床效果。结果观察组患儿的不良事件发生率、大便性状正常率、腹泻率、大便次数、临床症状消失时间、住院总耗时均显著优于对照组(P<0.05);观察组患儿的治疗总有效率为96.67%,明显高于对照患儿的63.33%(P<0.05)。结论金双歧联合思密达治疗小儿腹泻效果显著。

Objective To explore the clinical effect of gold dichotomous combined with smecta in the treatment of infantile diarrhea. Methods Sixty cases of patients with infantile diarrhea in our hospital from August 2013 to August 2014 were selected. All children were dynamically randomly classified into two groups, with 30 cases in each group, according to the principle of dynamic random grouping words, the patients in the control group and observation group were respectively given the routine therapy and gold dichotomous combined with smecta, the clinical effects of the two groups were observed. Results The incidence of adverse events, normal rate of stool, diarrhea rate, stool frequency, disappearance of clinical symptoms, total hospitalization time of the observation group were better than those of the control group （P〈0.05）; the total effective rate of the observation group was 96.67%, which was higher than 63.33% of the control group （P〈0.05）. Conclusion The clinical effect of gold dichotomous combined with smecta in the treatment of infantile diarrhea is remarkable.